|
1
|
Crittenden DB and Pillinger MH: The year
in gout: 2011–2012. Bull NYU Hosp Jt Dis. 70:145–151. 2012.
|
|
2
|
Richette P and Bardin T: Gout. Lancet.
23:318–328. 2010. View Article : Google Scholar
|
|
3
|
Liu-Bryan R, Scott P, Sydlaske A, Rose DM
and Terkeltaub R: Innate immunity conferred by Toll-like receptors
2 and 4 and myeloid differentiation factor 88 expression is pivotal
to monosodium urate monohydrate crystal-induced inflammation.
Arthritis Rheum. 52:2936–2946. 2005. View Article : Google Scholar
|
|
4
|
Liu-Bryan R, Pritzker K, Firestein GS and
Terkeltaub R: TLR2 signaling in chondrocytes drives calcium
pyrophosphate dihydrate and monosodium urate crystal-induced nitric
oxide generation. J Immunol. 174:5016–5023. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bustamante J, Tamayo E, Flórez S, Telleria
JJ, Bustamante E, López J, San Román JA, et al: Toll-like receptor
2 ARG753GLN polymorphisms are associated with an increased risk of
infective endocarditis. Rev Esp Cardiol. 64:1056–1059. 2011.
|
|
6
|
Karaca N, Ozturk G, Gerceker BT, Turkmen M
and Berdeli A: TLR2 and TLR4 gene polymorphisms in Turkish vitiligo
patients. J Eur Acad Dermatol Venereol. 27:85–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salpietro C, Rigoli L, Miraglia Del
Giudice M, et al: TLR2 and TLR4 gene polymorphisms and atopic
dermatitis in Italian children: a multicenter study. Int J
Immunopathol Pharmacol. 24:33–40. 2011.PubMed/NCBI
|
|
8
|
Hussein YM, Awad HA, Shalaby SM, Ali AS
and Alzahrani SS: Toll-like receptor 2 and Toll-like receptor 4
polymorphisms and susceptibility to asthma and allergic rhinitis: a
case-control analysis. Cell Immunol. 274:34–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brown RA, Gralewski JH and Razonable RR:
The ARG753GLN polymorphism abrogates toll-like receptor 2 signaling
in response to human cytomegalovirus. Clin Infect Dis. 49:96–99.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Theodoropoulos GE, Saridakis V, Karantanos
T, et al: Toll-like receptors gene polymorphisms may confer
increased susceptibility to breast cancer development. Breast.
21:534–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Oliveira JG and Silva AE: Polymorphisms
of the TLR2 and TLR4 genes are associated with risk of gastric
cancer in a Brazilian population. World J Gastroenterol.
18:1235–1242. 2012.PubMed/NCBI
|
|
12
|
Mandal RK, George GP and Mittal RD:
Association of Toll-like receptor (TLR) 2, 3 and 9 genes
polymorphism with prostate cancer risk in North Indian population.
Mol Biol Rep. 39:7263–7269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wallace SL, Robinson H, Masi AT, Decker
JL, McCarty DJ and Yü TF: Preliminary criteria for the
classification of the acute arthritis of primary gout. Arthritis
Rheum. 20:895–900. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoon HJ, Choi JY, Kim CO, et al: Lack of
Toll-like receptor 4 and 2 polymorphisms in Korean patients with
bacteremia. J Korean Med Sci. 21:979–982. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Punzi L, Scanu A, Ramonda R and Oliviero
F: Gout as autoinflammatory disease: new mechanisms for more
appropriated treatment targets. Autoimmun Rev. 12:66–71. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pimentel-Nunes P, Teixeira AL, Pereira C,
et al: Functional polymorphisms of Toll-likereceptors 2 and 4 alter
the risk for colorectalcarcinoma in Europeans. Dig Liver Dis.
45:63–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kutsenko NL, Izmaĭlova OV, Vesnina LÈ and
Kaĭdashev IP: Relationship of toll-like receptors 2 and 4 genes
polymorphisms with allergic diseases with increased levels of
specific IgE. Tsitol Genet. 46:59–66. 2012.(In Russian).
|
|
18
|
Xiong Y, Song C, Snyder GA, Sundberg EJ
and Medvedev AE: ARG753GLN polymorphism inhibits Toll-like receptor
(TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and
recruitment of myeloid differentiation primary response protein 88.
J Biol Chem. 287:38327–38337. 2012. View Article : Google Scholar
|
|
19
|
Bali P, Pradhan S, Sharma D and Adak T:
Toll like receptor 2 and 4 polymorphisms in malaria endemic
populations of India. Hum Immunol. 74:223–229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Myles A and Aggarwal A: Lack of
association of single nucleotide polymorphisms in toll-like
receptors 2 and 4 with enthesitis-related arthritis category of
juvenile idiopathic arthritis in Indian population. Rheumatol Int.
33:417–421. 2013. View Article : Google Scholar
|
|
21
|
Chen L, Lin MJ, Zhan Ll and Lv XP:
Analysis of TLR4 and TLR2 polymorphisms in inflammatory bowel
disease in a Guangxi Zhuang population. World J Gastroenterol.
18:6856–6860. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu F, Lu W, Qian Q, Hu J and Feng B:
Frequency of TLR 2, 4, and 9 gene polymorphisms in Chinese
population and their susceptibility to type 2 diabetes and coronary
artery disease. J Biomed Biotechnol. 2012:3739452012.PubMed/NCBI
|
|
23
|
Singh V, Srivastava N, Kapoor R and Mittal
RD: Single-nucleotide polymorphisms in genes encoding toll-like
receptor -2, -3, -4 and -9 in a case-control study with bladder
cancer susceptibility in a North Indian population. Arch Med Res.
44:54–61. 2013. View Article : Google Scholar
|
|
24
|
Yu JT, Mou SM, Wang LZ, Mao CX and Tan L:
Toll-like receptor 2 −196 to −174 del polymorphism influences the
susceptibility of Han Chinese people to Alzheimer’s disease. J
Neuroinflammation. 11:1362011.
|
|
25
|
Zeng HM, Pan KF, Zhang Y, et al: Genetic
variants of toll-like receptor 2 and 5, helicobacter pylori
infection, and risk of gastric cancer and its precursors in a
chinese population. Cancer Epidemiol Biomarkers Prev. 20:2594–2602.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hishida A, Matsuo K, Goto Y, Naito M,
Wakai K, Tajima K and Hamajima N: No associations of Toll-like
receptor 2 (TLR2) −196 to −174del polymorphism with the risk of
Helicobacter pylori seropositivity, gastric atrophy, and
gastric cancer in Japanese. Gastric Cancer. 13:251–257. 2010.
|
|
27
|
Lee YH, Bae SC, Kim JH and Song GG:
Toll-like receptor polymorphisms and rheumatoid arthritis: a
systematic review. Rheumatol Int. Jan 17–2013.(Epub ahead of
print).
|
|
28
|
Abu-Amero KK, Jaeger M, Plantinga T, Netea
MG and Hassan HY: Genetic variation of TLR2 and TLR4 among the
Saudi Arabian population: insight into the evolutionary dynamics of
the Arabian Peninsula. Genet Test Mol Biomarkers. 17:166–169. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takeda K, Kaisho T and Akira S: Toll-like
receptors. Annu Rev Immunol. 21:335–376. 2003. View Article : Google Scholar
|
|
30
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: update on
Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mylona EE, Mouktaroudi M, Crisan TO, et
al: Enhanced interleukin-1β production of PBMCs from patients with
gout after stimulation with Toll-like receptor-2 ligands and urate
crystals. Arthritis Res Ther. 14:R1582012.
|
